3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
3
Phase 1/2
2
Phase NA
1
Phase 1
1
Status
Completed
38
Recruiting
12
Terminated
10
Active not recruiting
7
Unknown
6
Withdrawn
5
Not yet recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Other solid neoplasm
1
Head & Neck
1
Genitourinary
1
Breast
1
Conditions
Carcinoma, Non-Small-Cell Lung
36
Leukemia, Myeloid, Acute
27
Colorectal Neoplasms
27
Neoplasms
26
Neoplasm Metastasis
22
Recurrence
21
Multiple Myeloma
20
Advanced Solid Tumors
20
Lymphoma, B-Cell
19
Breast Neoplasms
18
Pancreatic Neoplasms
14
Lung Neoplasms
13
Glioblastoma
13
Carcinoma, Hepatocellular
13
Lymphoma
12
Brain Neoplasms
12
Precursor Cell Lymphoblastic Leukemia-Lymphoma
11
Hematologic Neoplasms
11
Glioma
11
Squamous Cell Carcinoma of Head and Neck
10
Ovarian Neoplasms
10
Melanoma
10
Leukemia
10
Advanced Solid Tumor
10
Triple Negative Breast Neoplasms
9
Prostatic Neoplasms
9
Head and Neck Neoplasms
9
Lymphoma, Non-Hodgkin
8
Esophageal Neoplasms
8
Myelodysplastic Syndromes
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Not yet recruiting
×
Mesothelioma, Malignant
×
Clear all
NCT05698238
2023-03-15
CAMP1
Mabpro, a.s.
Phase 1
Not yet recruiting
50 enrolled